Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine

References

• AichbergerKJHerndlhoferSAgisH2007Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapyEur J Clin Invest378081317727673
   PubMed Web of Science ®Google Scholar
• AnaclericoBBongarzoniVChierichiniA2006Liposomal cytarabine in the central nervous system (CNS) prophylaxis of elderly patients with aggressive B-cell non-Hodgkin’s lymphoma (NHL) and undifferentiated acute leukemia (UAL): preliminary results of a single-center experienceASH Annual Meeting Abstracts1084663
   Google Scholar
• AngstMSDroverDR2006Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technologyClin Pharmacokinet4511537617112293
   PubMed Web of Science ®Google Scholar
• BanghamADStandishMMWatkinsJC1965Diffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol13238525859039
   PubMed Web of Science ®Google Scholar
• BeneschMSovinzPKrammerB2007Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitisJ Pediatr Hematol Oncol29222617414563
   PubMed Web of Science ®Google Scholar
• BeneschMUrbanC2008Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developmentsExpert Opin Pharmacother9301918201152
   PubMed Web of Science ®Google Scholar
• BjörgvinsdóttirHHeldrupJBékássyAN2006Intrathecal liposomal cytarabine: clinical experience in pediatric leukemia and neuroblastoma patientsPediatr Blood Cancer47Suppl 4444
   Google Scholar
• BleyerWA1999Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentariumClin Cancer Res533495110589743
   PubMed Web of Science ®Google Scholar
• BrionAHeliasPDanguindauE2007Efficacy and safety of intrathecal depocyte (liposomal cytarabine) in patients with primary CNS lymphoma (PCNSL) or leukaemic meningitis associated with acute leukaemias: a single institution experience in FranceHaematologica92s1274
   Google Scholar
• BrombergJEBreemsDAKraanJ2007CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignanciesNeurology681674917502548
   PubMed Web of Science ®Google Scholar
• CameraACercielloGPernaF2006Liposomal Cytarabine (Depocyte®) for the treatment of meningeal or CNS disease in acute leukemias (AL) and non-Hodgkin lymphomas (NHL): a single centre experienceASH Annual Meeting Abstracts1084540
   Google Scholar
• CascavillaNBodenizzaCCarellaAM2006Use of intrathecal liposomal cytarabine (DepoCyte) as treatment of lymphomatous meningitisASH Annual Meeting Abstracts1084677
   Google Scholar
• ChamberlainMC2005Neoplastic meningitisJ Clin Oncol2336051315908671
   PubMed Web of Science ®Google Scholar
• ChamberlainMCGlantzMJ2007Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaBlood110169817712051
   PubMed Web of Science ®Google Scholar
• DeAngelisLM1998Current diagnosis and treatment of leptomeningeal metastasisJ Neurooncol38245529696379
   PubMed Web of Science ®Google Scholar
• Garcia-MarcoJANavarroBRuiz SanzE2006Efficacy and safety of DepoCyte® (liposomal cytarabine) in patients with CNS involvement from non-Hodgkin’s lymphoma (NHL): a report on 32 patients treated in SpainASH Annual Meeting Abstracts108112451
   Google Scholar
• GlantzMJJaeckleKAChamberlainMC1999aA randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyte®) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Res5339440210589750
   PubMed Web of Science ®Google Scholar
• GlantzMJLaFolletteSJaeckleKA1999bRandomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitisJ Clin Oncol173110610506606
   PubMed Web of Science ®Google Scholar
• GoekbugetNBassaRHugS2005First promising results from an European trail with liposomal cytarabine (Depocyte®) for intrathecal (i.th) application in CNS relapse acute lymphoblastic leukemia (ALL) or aggressive lymphoma (vaNHL)Onkologie28Suppl 3787
   Google Scholar
• HofheinzRDGnad-VogtSUBeyerU2005Liposomal encapsulated anti-cancer drugsAnticancer Drugs1669170716027517
   PubMed Web of Science ®Google Scholar
• JabbourEO’BrienSKantarjianH2007Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaBlood1093214817209054
   PubMed Web of Science ®Google Scholar
• JohnsonSA2001Nucleoside analogues in the treatment of haematological malignanciesExpert Opin Pharmacother29294311585009
   PubMedGoogle Scholar
• KimSChatelutEKimJC1993Extended CSF cytarabine exposure following intrathecal administration of DTC 101J Clin Oncol112186938229133
   PubMed Web of Science ®Google Scholar
• KimSKimDJGeyerMA1987Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapyCancer Res47393573607740
   PubMed Web of Science ®Google Scholar
• McCluneBBuadiFKAslamN2007Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphomaLeuk Lymphoma4818495117786723
   PubMed Web of Science ®Google Scholar
• MoeremansKAnnemansLMorrisJ2004Liposomal cytarabine (DepoCyteTM injection) is cost-effective compared with standard cytarabine for the intrathecal treatment of patients with lymphomatous meningitisASH Annual Meeting Abstracts104267
   Google Scholar
• NeumeisterPNPfeilstöckerMLinkeschW2007Safety and tolerability of intrathecal liposomal cytarabine as CNS prophylaxis in patients with acute lymphoblastic leukemia (ALL)Haematologica92s18
   Google Scholar
• Perez-SolerR1989Liposomes as carriers of antitumor agents: toward a clinical realityCancer Treat Rev1667822670206
   PubMed Web of Science ®Google Scholar
• PuiCH2007Toward optimal use of intrathecal liposomal cytarabineLeuk Lymphoma481672317786701
   PubMed Web of Science ®Google Scholar
• ResarLMPhillipsPCKastanMB1991Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell typeCancer71117238416707
   PubMed Web of Science ®Google Scholar
• RossiDAnninoLBongarzoniV2006Efficacy and tolerability of liposomial cytosine arabinoside (DepoCyte®) for the treatment of lymphomatous and leukemic meningitisASH Annual Meeting Abstracts1084674
   Google Scholar
• SanchoJMDebenGParkerA2007Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosisInt J Hematol8633617675264
   PubMed Web of Science ®Google Scholar
• SanchoJ-MGiraldoPRomeroM-J2006aCompassionate use of intrathecal depot cytarabine (DepoCyte®) in central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma in Spain: Report of 10 casesASH Annual Meeting Abstracts1084518
   Google Scholar
• SanchoJMRiberaJMRomeroMJ2006bCompassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 casesHaematologica91ECR0216533729
   PubMed Web of Science ®Google Scholar
• SchillerGGajewskiJTerritoM1992Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemiaBlood802977821467513
   PubMed Web of Science ®Google Scholar
• SeniorJGregoriadisG1982Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol componentsLife Sci302123367109841
   PubMed Web of Science ®Google Scholar
• SessaGWeissmannG1968Phospholipid spherules (liposomes) as a model for biological membranesJ Lipid Res931085646182
   PubMed Web of Science ®Google Scholar
• ShapiroWRSchmidRGlantzM2006A randomized Phase III/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitisJ Clin Oncol24Suppl 18S1528
   Google Scholar
• WeissHDWalkerMDWiernikPH1974Neurotoxicity of commonly used antineoplastic agents (first of two parts)N Engl J Med29175814599221
   PubMed Web of Science ®Google Scholar
• ZimmSCollinsJMMiserJ1984Cytosine arabinoside cerebrospinal fluid kineticsClin Pharmacol Ther35826306587957
   PubMed Web of Science ®Google Scholar